Moyamoya Vasculopathy
Conditions
Interventions
Sponsors
The First Hospital of Hebei Medical University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Patients diagnosed with moyamoya disease or moyamoya syndrome by imaging examination (such as cerebral angiography, etc.); 2. Age< 80 years old; 3. Patients or their legal representatives are able to understand and consent to the information collection of this study and sign an informed consent form. 4. Willing to accept follow-up by the research team.
Exclusion criteria
Exclusion criteria: 1. Refusal of the patient or his/her legal representative to participate in this study. 2. Combined with other serious neurological diseases that may affect the evaluation of the results of this study. 3. Presence of severe hepatic and renal insufficiency or other systemic diseases, which may affect the patient's survival or treatment decision. 4. Other conditions that the investigator considers the patient to be unsuitable for participation in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pharmacotherapy group - hemorrhagic or ischemic stroke occurs;Pharmacotherapy group - neurological prognosis;Pharmacotherapy group - Deaths during 24-month follow-up;Surgical treatment group/endovascular intervention treatment group - Vascular patency status;Surgical treatment group/endovascular intervention treatment group - Onset of hemorrhagic/ischemic stroke;Surgical treatment group/endovascular intervention treatment group - death;Surgical treatment group/endovascular intervention treatment group - cerebral vascular status; | — |
Secondary
| Measure | Time frame |
|---|---|
| Pharmacotherapy group - radiographic progression;Pharmacotherapy group - quality of life and cognitive impairment;Surgical treatment group/endovascular intervention treatment group - periprocedural complication;Surgical treatment group/endovascular intervention treatment group - Neurological function;Surgical treatment group/endovascular intervention treatment group - quality of life and cognitive impairment; | — |
Countries
China
Contacts
Public ContactLi Conghui
The First Hospital of Hebei Medical University
Outcome results
None listed